Rhodocollybia maculata
Species of fungus
From Wikipedia, the free encyclopedia
Rhodocollybia maculata, commonly known as the spotted toughshank, is a species of basidiomycete fungus in the family Omphalotaceae.[2] R. maculata is a source of collybolide, a sesquiterpenoid containing a furyl-ẟ-lactone motif reminiscent of salvinorin A.
| Rhodocollybia maculata | |
|---|---|
| Scientific classification | |
| Kingdom: | Fungi |
| Division: | Basidiomycota |
| Class: | Agaricomycetes |
| Order: | Agaricales |
| Family: | Omphalotaceae |
| Genus: | Rhodocollybia |
| Species: | R. maculata |
| Binomial name | |
| Rhodocollybia maculata (Alb. & Schwein.: Fr.) Singer[1] | |
| Synonyms | |
|
Collybia maculata | |
| Rhodocollybia maculata | |
|---|---|
| Mycological characteristics | |
| Gills on hymenium | |
| Cap is convex or flat | |
| Hymenium is adnexed | |
| Stipe is bare | |
| Spore print is pink to cream | |
| Ecology is saprotrophic | |
| Edibility is edible, but unpalatable | |
Description
The cap is up to 9 centimetres (3+1⁄2 in) wide and cream-colored with red-brown spots.[3] The edge remains inrolled for an extended period of time. The whitish gills are crowded, becoming spotted in age. The similarly colored stipe is up to 10 cm long,[3] tough, hollow, and tapered downwards.[4] The spore print is whitish to yellowish.[3]
A variety known as scorzonerea is characterized by yellowish color of its gills, and sometimes the stipe.[4]
Distribution and habitat
Edibility
Kappa-opioid receptor agonism
In 2016, Gupta et al. reported that collybolide exhibited high-potency, selective kappa-opioid receptor (KOR) agonism.[8] Due to its attractive bioactivity and chemical similarity to salvinorin A, collybolide garnered attention in the synthetic chemistry and pharmacology fields as a potential scaffold for developing next-generation analgesics, antipruritics, and antidepressants.[9][10][11]
In 2022, Shevick et al. completed the first enantioselective total synthesis of collybolide and profiled the activity of synthetic collybolide at the KOR. Despite previous findings by Gupta et al., these assays showed that neither enantiomer of collybolide had KOR activity.[12] The synthetic sample was identical to natural collybolide isolated from R. maculata. Assays of crude R. maculata extracts by other groups additionally showed no KOR activity.[12][Note 1] These assays of synthetic and natural samples contradict the findings of Gupta et al., and suggest that collybolide and the other constituents of R. maculata have no activity at KOR.
Gallery
Notes
- See page 150 of the Supporting Information of Shevick et al. for reports on the kappa-opioid receptor assays with crude R. maculata extracts.